IONS

As of 2026-09-11, IONS scores 14out of 100 on QNTM’s five-factor quantitative model, a low conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. IONS trades at $54.21, within its fair-value band.

IONS scores 14 out of 100 on QNTM's five-factor model — a low-conviction reading — at 14 the factor profile is among the weaker names in the universe. Its strongest factor is volume at 41 (middling), where trading volume confirms genuine accumulation, followed by quality at 15. The weakest is value at 0, where valuation looks stretched. Among Healthcare stocks it sits in the lower 0% of Healthcare names by composite.

On valuation, IONS is priced near the floor of its own recent range — the cheap end on the model's valuation read. The blended composite before the macro overlay was 14. Same-sector names the model rates nearby include HALO, THC, HNGE.

This is a descriptive factor read on IONS, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where IONS sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for IONS runs $52.47–$84.77. Current price $54.21 sits within its fair-value band. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-11.